Print Print page | E-mail E-mail page | PDF Download PDF
« Previous Release | Next Release »


Shareholders of Harris & Harris Group, Inc., may be interested to read articles covering Toshiba Semiconductor Co.' validation of Molecular Imprints Inc.' nano-imprint lithography technology for 22nm node CMOS devices. The results were presented by Toshiba last month at the 33rd International Conference on Micro- and Nano- Engineering (MNE) in Copenhagen, Denmark. You may access the detailed articles in Semiconductor International at or in Electronic News at;=CA6491602.

Harris & Harris Group is a shareholder in privately held Molecular Imprints, Inc.

Harris & Harris Group is a publicly traded venture capital company that makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 36 initial private equity investments have been in tiny technology-enabled companies.

Detailed information about Harris & Harris Group and its holdings can be found on its website at

This news release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect the Company's current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this news release. Please see the Company's Registration Statement on Form N-2 and Annual Report on Form 10-K for the year ended December 31, 2006, as well as subsequent SEC filings, filed with the Securities and Exchange Commission for a more detailed discussion of the risks and uncertainties associated with the Company's business, including but not limited to the risks and uncertainties associated with venture capital investing and other significant factors that could affect the Company's actual results. Except as otherwise required by Federal securities laws, Harris & Harris Group, Inc., undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties. The reference to the websites, and, have been provided as a convenience, and the information contained on such websites are not incorporated by reference into this news release.

TEL. NO. (212) 582-0900

Close window | Back to top